Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cognitive Impairment in Multiple Sclerosis: Clinical Manifestation, Neuroimaging Correlates, and Treatment.
A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan.
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Mitoxantrone: benefits and risks in multiple sclerosis patients.
Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.
IFN-β inhibits T cells accumulation in the central nervous system by reducing the expression and activity of chemokines in experimental autoimmune encephalomyelitis.
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.
A Pilot Trial of Interferon beta-1a in Alzheimer's Disease
Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.
Fingolimod versus intramuscular interferon in patient subgroups from TRANSFORMS.
Clinical utility of the list sign as a predictor of non-demyelinating disorders in a multiple sclerosis (MS) practice.
Channelopathy-related SCN10A gene variants predict cerebellar dysfunction in multiple sclerosis.
Flupirtine shows functional NMDA receptor antagonism by enhancing Mg2+ block via activation of voltage independent potassium channels. Rapid communication.
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Site-Specific PEGylation Enhances the Pharmacokinetic Properties and Antitumor Activity of Interferon Beta-1b.
Interferon-beta(1b) treatment in neuromyelitis optica.
Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.
Statement on a nonproprietary name adopted by the USAN Council
Estriol Treatment in Multiple Sclerosis: Effect on Cognition
Multiple sclerosis: clinical presentation, diagnosis and treatment.
EMD Serono Takes on Exclusive Promotion of Rebif® (interferon beta-1a) in the US
US and EU regulatory authorities accept PLEGRIDY™ (peginterferon beta-1a) marketing applications for review
A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field.

Pages